Their further studies revealed that NLRP3 inflammatory vesicles promote malignant transformation of PCa through activation of caspase-1, providing new possible prognostic biomarkers and potential therapeutic targets for PCa [50]. Here, CASP1 is linked to posterior cortical atrophy.